Home Biosimilar Antibodies Transmembrane Transporters Sodium Channel Lifastuzumab vedotin (Anti-SLC34A2)
For research use only. Not for use in humans.

Lifastuzumab vedotin (Anti-SLC34A2)

Synonyms: NaPi3b

Lifastuzumab vedotin (Anti-SLC34A2) is a monoclonal antibody targeting SLC34A2 (sodium phosphate 2 transporter(NaPi2b)). It has anticancer activity and can be used in research of ovarian cancer (OC).

Lifastuzumab vedotin (Anti-SLC34A2)

Quality Control

  • Cited in Nature Medicine for its top-tier quality
  • SDS
  • Datasheet

Specificity

Name Citation Sodium Channel Others
A-803467 2
Camostat Mesilate 16
Ambroxol HCl 0
Flecainide hydrochloride 0
Suzetrigine (VX-548) 0
Tenapanor 0
SEA0400 0 ROS,ERK,p38 MAPK
SLC13A5-IN-1 0
LTGO-33 0
EIPA (L593754) 8
Vernakalant (RSD1235) Hydrochloride 0
QX-314 chloride 0
VX-150 0
Rimeporide 0
(-)-Sparteine Sulfate 0
Benzocaine 0
Tolperisone HCl 1
Vinpocetine 1
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Lifastuzumab vedotin (Anti-SLC34A2) is a monoclonal antibody targeting SLC34A2 (sodium phosphate 2 transporter(NaPi2b)). It has anticancer activity and can be used in research of ovarian cancer (OC).
References

Product Details

CAS No. 1615697-16-9
Isotype Human IgG1
Source CHO
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.